Account
Famous Innovations Delhi Wins Adidas India after a multi-agency pitch
Mumbai: Famous Innovations Delhi, an independent creative agency is proud to announce its successful acquisition of the prestigious Adidas India social mandate. This collaboration reinforces Famous Innovations Delhi’s reputation as a leading creative force, with an impressive track record of accolades and a diverse client portfolio.
“We are thrilled to collaborate with Famous Innovations on our social mandate,” said Sunil Gupta, senior director – brand Adidas. “Their strategic thinking and creative approach make them the ideal partner to amplify our social initiatives and engage with our audience meaningfully.”
Famous Innovations founding partner Sumit Chaurasia expressed his excitement: “Winning the Adidas India social mandate is a testament to our team’s dedication and expertise. We are committed to leveraging our creativity and strategic approach to drive impactful campaigns that resonate with people and create positive change.”
Famous Innovations is the foremost creative agency, renowned for its groundbreaking campaigns and award-winning achievements. With eight wins as South Asia Independent Agency of the Year, two-time Digital Agency of the Year, and ranking as the second-most awarded agency at Goafest Abby’s x The One Show 2022, Famous Innovations consistently delivers impactful solutions for a diverse range of clients. Their portfolio includes American Tourister, Haier, Titan, Times Group, Unilever, Van Heusen, Platinum Jewelry, Pernod Ricard, AB InBev, and many more.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
